Table 1:
Baseline patient demographicsa
| All Patients (n = 341) | Endovascular Therapy (n = 133) | IV tPA-Only (n = 61) | No Reperfusion Therapy (n = 147) | |
|---|---|---|---|---|
| Cost (median) (IQR) | $16,446 | $21,871 | $14,456 | $13,401 |
| ($9823–$27,165) | ($15,672–$31,363) | ($7626–$19,701) | ($8308–$23,589) | |
| Age (median) (IQR) | 69 (57–80) | 68 (58–80) | 75 (59–83) | 66 (55–79) |
| Female | 165 (48.4%) | 65 (48.9%) | 33 (54.1%) | 67 (45.6%) |
| A. Fib | 162 (47.5%) | 65 (48.9%) | 37 (60.7%) | 60 (40.9%) |
| Alcohol abuse | 27 (7.9%) | 7 (5.3%) | 4 (6.6%) | 16 (10.9%) |
| Anticoagulation | 29 (8.5%) | 11 (8.3%) | 5 (8.2%) | 13 (8.8%) |
| CAD | 78 (23.0%) | 26 (19.6%) | 19 (31.7%) | 33 (22.6%) |
| CAS | 72 (21.1%) | 23 (17.3%) | 10 (16.4%) | 39 (26.5%) |
| CHF | 59 (17.5%) | 15 (11.4%) | 17 (28.3%) | 27 (18.5%) |
| CKD | 19 (5.6%) | 3 (2.3%) | 4 (6.7%) | 12 (8.2%) |
| Dementia | 15 (4.4%) | 2 (1.5%) | 7 (11.7%) | 6 (4.1%) |
| Dissection | 17 (5.0%) | 9 (6.8%) | 2 (3.3%) | 6 (4.1%) |
| DMII | 103 (30.2%) | 51 (38.3%) | 25 (41.0%) | 27 (18.4%) |
| Hyperlipidemia | 149 (43.7%) | 64 (48.1%) | 29 (47.5%) | 56 (38.1%) |
| Hypertension | 291 (85.3%) | 111 (83.5%) | 55 (90.2%) | 125 (85.0%) |
| Illicit drug use | 8 (2.3%) | 0 (0.0%) | 0 (0.0%) | 8 (5.5%) |
| Obesity | 44 (12.9%) | 12 (9.0%) | 19 (31.1%) | 13 (8.8%) |
| OSA | 31 (9.2%) | 12 (9.0%) | 8 (13.1%) | 11 (7.5%) |
| Psychiatric | 33 (9.7%) | 9 (6.8%) | 7 (11.5%) | 17 (11.6%) |
| Tobacco | 124 (36.6%) | 40 (30.1%) | 21 (34.4%) | 63 (42.9%) |
Note:—A. Fib indicates atrial fibrillation; CAD, coronary artery disease; Dissection, ipsilateral carotid dissection; CAS, ipsilateral carotid artery stenosis; CHF, congestive heart failure; CKD, chronic kidney disease; DMII, diabetes mellitus II; OSA, obstructive sleep apnea; Psychiatric, any psychiatric comorbidity.
a
Values represent total number and percentage unless otherwise indicated.